how long have glp-1 been on the market Obesity How Supply and Demand for

Microdosing GLP-1 for autoimmune conditions is an area of active investigation, and conditions like Hashimoto thyroiditis and endometriosis have both been explored in the context of GLP-1 therapy

Our account teams are prepared to consult with you on a coverage strategy that makes sense for your business and plan members, including flexible coverage options, if desired

Note that at the higher doses with a 2.5 mg/mL concentration, you are injecting nearly a full mL of fluid

The authors also observed the maintenance of serum creatinine and urea nitrogen (markers of stable renal function) and reduced disease progression in the FMT group (Arteaga-Muller et al., 2024)

People Already on Blood Pressure Medications If you already take blood pressure medications, starting a GLP-1 drug might make your blood pressure drop more

This risk may affect treatment continuation in some patients